(Q44024571)

29 November 2017

title

Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline (English)

1 reference

29 November 2017

1 reference

1

Peter R Joyce

1 reference

29 November 2017

2

Roger T Mulder

1 reference

29 November 2017

3

Suzanne E Luty

1 reference

29 November 2017

4

Patrick F Sullivan

1 reference

29 November 2017

5

Janice M McKenzie

1 reference

29 November 2017

Robyn M Abbott

6

1 reference

29 November 2017

Isobel F Stevens

series ordinal

7

1 reference

29 November 2017

publication date

1 June 2002

1 reference

Australian and New Zealand Journal of Psychiatry

29 November 2017

published in

1 reference

29 November 2017

volume

36

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

384-391

1 reference

The definition and operational criteria for treatment outcome of major depressive disorder. A review of the current research literature

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.01026.X

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.01026.X

Effects of exclusion criteria in depression treatment studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.01026.X

Family history of depression in clinic and community samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.01026.X

Predictors of drug response in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.01026.X

The hypothalamic-pituitary-thyroid axis in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.01026.X

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.01026.X

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.01026.X

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.01026.X

Assessment of social adjustment by patient self-report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.01026.X

A psychobiological model of temperament and character

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.01026.X

Gender differences in treatment response to sertraline versus imipramine in chronic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.01026.X

Effect of antidepressant therapy on health care utilization and costs in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.01026.X

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.01026.X

Are the newer antidepressant drugs as effective as established physical treatments? Results from an Australasian clinical panel review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.01026.X

Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.01026.X

10.1046/J.1440-1614.2001.01026.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference